Altre lingue Beyond Air, Inc.

Azioni

XAIR

US08862L1035

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 10/05/2024			Variaz. 5gg	Var. 1 gen.
1,15 ^USD	-3,36%		-11,54%	-41,33%

30/04	BEYOND AIR, INC. : giudizio positivo da Truist Securities	ZM
12/02	Beyond Air, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting	01/05
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants	20/03
Beyond Air : Corporate Presentation	13/03
Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year 2025	12/02
Earnings Flash (XAIR) BEYOND AIR Posts Q3 Revenue $391,000, vs. Street Est of $0.45M	12/02
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024	12/02
North American Morning Briefing : Stock Futures Steady as Traders Await CPI Data	12/02
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast	18/01
Beyond Air Affiliate Says First Group Cleared in Phase 1 UNO Study in Solid Tumors; Shares Rise	27/12
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors	27/12
Thinking about buying stock in Polished.Com, Mereo BioPharma, Fusion Pharmaceuticals, Luminar Technologies, or Beyond Air?	20/12
Beyond Air Insider Bought Shares Worth $1,962,000, According to a Recent SEC Filing	19/12
Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference	15/11
Thinking about buying stock in Invo Bioscience, Singing Machine Company, Beauty Health, Beyond Air, or Tivic Health Systems?	14/11
Beyond Air, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	13/11
Earnings Flash (XAIR) BEYOND AIR Reports Q2 Revenue $239,000, vs. Street Est of $482,000	13/11
Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024	13/11
Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year Ending March 31, 2025	13/11
Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting	03/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Beyond Air, Inc.

Azioni

XAIR

US08862L1035

Altre lingue

Filtri